Global Icariin Sales Market Report 2021

Icariin is a flavonol glycoside and a PDE5 inhibitor (IC50 = 5.9 μM) with 67-fold selectivity for PDE5 over PDE4. It exhibits antioxidant and anticancer activity. At a concentration of 1 x 107 mol/L, Icariin induces differentiation of cardiomyocytes and upregulates the expression of cardiac genes. At 20 μg/ml, Icariin increases the proliferation and differentiation of cultured human osteoblasts. Icariin affects the aging mechanism from different aspects, can delay the aging process and prevent the occurrence of senile diseases.

Market Analysis and Insights: Global Icariin Market
The global Icariin market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Icariin Scope and Market Size
The global Icariin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Icariin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Less Than 98%
More Than 98%

Segment by Application
Ingredient of Health Care Products
Research

The Icariin market is analysed and market size information is provided by regions (countries). Segment by Application, the Icariin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
BOC Sciences
BLDpharm
Pharmaffiliates
ChemScence
AdooQ BioScience
ApexBio Technology
EXTRASYNTHESE
Merck
Abcam
Targetmol
Ivy Fine Chemicals
Cayman Chemical

Frequently Asked Questions